Found: 3
Select item for more details and to access through your institution.
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article